ArticleCancer medicine2019

Everolimus-containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study.

Zhanhong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.